Annual SGA
$26.09 M
-$2.39 M-8.39%
December 31, 2024
Summary
- As of March 10, 2025, ALXO annual SGA is $26.09 million, with the most recent change of -$2.39 million (-8.39%) on December 31, 2024.
- During the last 3 years, ALXO annual SGA has risen by +$2.71 million (+11.58%).
- ALXO annual SGA is now -10.13% below its all-time high of $29.04 million, reached on December 31, 2022.
Performance
ALXO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.08 M
+$985.00 K+16.16%
December 31, 2024
Summary
- As of March 10, 2025, ALXO quarterly SGA is $7.08 million, with the most recent change of +$985.00 thousand (+16.16%) on December 31, 2024.
- Over the past year, ALXO quarterly SGA has stayed the same.
- ALXO quarterly SGA is now -7.73% below its all-time high of $7.67 million, reached on March 31, 2022.
Performance
ALXO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.30 B
-$134.85 M-6.24%
December 31, 2024
Summary
- As of March 10, 2025, ALXO TTM SGA is -$2.30 billion, with the most recent change of -$134.85 million (-6.24%) on December 31, 2024.
- Over the past year, ALXO TTM SGA has dropped by -$2.32 billion (-8899.67%).
- ALXO TTM SGA is now -3054.88% below its all-time high of -$72.78 million.
Performance
ALXO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ALXO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.4% | 0.0% | -8899.7% |
| 3 y3 years | +11.6% | -7.7% | -8700.0% |
| 5 y5 years | +687.6% | +62.5% | -10000.0% |
ALXO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.1% | +11.6% | -7.7% | +17.1% | -249.4% | at low |
| 5 y | 5-year | -10.1% | +687.6% | -7.7% | +539.1% | -3054.9% | at low |
| alltime | all time | -10.1% | +903.2% | -7.7% | +1104.3% | -3054.9% | at low |
ALX Oncology Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $26.09 M(-8.4%) | $7.08 M(+16.2%) | $26.09 M(+3.3%) |
| Sep 2024 | - | $6.10 M(-11.3%) | $25.25 M(-5.3%) |
| Jun 2024 | - | $6.87 M(+13.7%) | $26.66 M(-1.6%) |
| Mar 2024 | - | $6.04 M(-3.1%) | $27.09 M(-4.9%) |
| Dec 2023 | $28.48 M(-1.9%) | $6.24 M(-16.9%) | $28.48 M(-2.7%) |
| Sep 2023 | - | $7.51 M(+2.9%) | $29.27 M(+0.7%) |
| Jun 2023 | - | $7.29 M(-1.9%) | $29.06 M(+0.9%) |
| Mar 2023 | - | $7.44 M(+6.0%) | $28.80 M(-0.8%) |
| Dec 2022 | $29.04 M(+24.2%) | $7.02 M(-3.8%) | $29.04 M(-1.9%) |
| Sep 2022 | - | $7.30 M(+3.7%) | $29.59 M(+3.3%) |
| Jun 2022 | - | $7.04 M(-8.2%) | $28.66 M(+7.3%) |
| Mar 2022 | - | $7.67 M(+1.3%) | $26.70 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $23.39 M(+57.9%) | $7.58 M(+19.1%) | $23.39 M(+8.8%) |
| Sep 2021 | - | $6.36 M(+25.1%) | $21.49 M(+9.6%) |
| Jun 2021 | - | $5.09 M(+16.7%) | $19.61 M(+10.8%) |
| Mar 2021 | - | $4.36 M(-23.3%) | $17.70 M(+19.5%) |
| Dec 2020 | $14.81 M(+347.0%) | $5.68 M(+26.8%) | $14.81 M(+44.7%) |
| Sep 2020 | - | $4.48 M(+41.3%) | $10.23 M(+53.0%) |
| Jun 2020 | - | $3.17 M(+115.3%) | $6.69 M(+59.4%) |
| Mar 2020 | - | $1.47 M(+32.9%) | $4.20 M(+26.7%) |
| Dec 2019 | $3.31 M(+27.4%) | $1.11 M(+18.1%) | $3.31 M(+50.2%) |
| Sep 2019 | - | $938.00 K(+38.1%) | $2.21 M(+74.0%) |
| Jun 2019 | - | $679.00 K(+15.5%) | $1.27 M(+115.5%) |
| Mar 2019 | - | $588.00 K | $588.00 K |
| Dec 2018 | $2.60 M | - | - |
FAQ
- What is ALX Oncology Holdings annual SGA?
- What is the all time high annual SGA for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual SGA year-on-year change?
- What is ALX Oncology Holdings quarterly SGA?
- What is the all time high quarterly SGA for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly SGA year-on-year change?
- What is ALX Oncology Holdings TTM SGA?
- What is the all time high TTM SGA for ALX Oncology Holdings?
- What is ALX Oncology Holdings TTM SGA year-on-year change?
What is ALX Oncology Holdings annual SGA?
The current annual SGA of ALXO is $26.09 M
What is the all time high annual SGA for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual SGA is $29.04 M
What is ALX Oncology Holdings annual SGA year-on-year change?
Over the past year, ALXO annual SGA has changed by -$2.39 M (-8.39%)
What is ALX Oncology Holdings quarterly SGA?
The current quarterly SGA of ALXO is $7.08 M
What is the all time high quarterly SGA for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly SGA is $7.67 M
What is ALX Oncology Holdings quarterly SGA year-on-year change?
Over the past year, ALXO quarterly SGA has changed by $0.00 (0.00%)
What is ALX Oncology Holdings TTM SGA?
The current TTM SGA of ALXO is -$2.30 B
What is the all time high TTM SGA for ALX Oncology Holdings?
ALX Oncology Holdings all-time high TTM SGA is -$72.78 M
What is ALX Oncology Holdings TTM SGA year-on-year change?
Over the past year, ALXO TTM SGA has changed by -$2.32 B (-8899.67%)